Palisade Bio (PALI) Capital Expenditures Growth (5y) (2015 - 2022)
Palisade Bio (PALI) Capital Expenditures Growth (5y) (2015 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,071.81 Bn | - |
| 2 | Nanobiotix | 1,925.70 Bn | 1,925.64 Bn | - |
| 3 | Akari Therapeutics | 1,062.88 Bn | 1,062.88 Bn | - |
| 4 | BeOne Medicines | 469.09 Bn | 464.29 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.09 Bn | 115.84 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.32 Bn | 61.57 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.36 Bn | 63.36 Bn | - |
| 8 | Argenx Se | 55.90 Bn | 50.71 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.69 Bn | 34.68 Bn | 959.66 Mn |
| 10 | Palisade Bio | 415.13 Mn | 282.51 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 22.68% |
| Dec 31, 2020 | -53.91% |
| Sep 30, 2020 | -14.96% |
| Jun 30, 2019 | -16.59% |
| Dec 31, 2018 | 54.23% |
| Mar 31, 2018 | 19.29% |
| Dec 31, 2017 | -27.92% |
| Sep 30, 2017 | -22.55% |
| Jun 30, 2017 | 33.46% |
| Sep 30, 2016 | 85.19% |
| Jun 30, 2016 | -69.48% |
| Mar 31, 2016 | -17.92% |
| Dec 31, 2015 | -0.12% |
| Sep 30, 2015 | 141.16% |